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Abstract 
Preterm infants frequently receive blood transfusion during their stay in neonatal unit, and its 
impact on organ perfusion and oxygenation is not clear. The aim of the study was to 
measure the effect of blood transfusion on cerebral blood flow and oxygenation in preterm 
infants in relation to chronological age. 
 
Fifty nine infants were studied: group 1=20, group 2=21 and group 3=18 infants with median 
age (range) at transfusion of 5 (1-7), 14 (8-27) and 45 (29-68) days respectively. Gestational 
age and birth weight of infants between groups were similar. Pre-transfusion vital 
parameters were similar between the groups except the heart rate was significantly higher in 
group 1 compared to group 3 (p=0.02). The mean BP increased significantly in all three 
groups and there were no significant changes in other vital parameters following transfusion. 
There was no change in pre and post transfusion pCO2 and pH in blood gas. The mean pre-
transfusion Anterior Cerebral artery (ACA) time averaged mean velocity (TAMV) increased 
significantly with chronological age (p<0.001), and ACA Peak Systolic Velocity (PSV) also 
increased with chronological age of infants but this was not significant. Pre-transfusion ACA 
TAMV and PSV decreased significantly (p≤0.04), and there was no change in ACA 
Resistance Index (RI) and Pulsatility Index (PI) following transfusion in infants of all 3 
groups. The pre-transfusion mean Superior Vena Cava (SVC) flow decreased significantly in 
Group 1 (p=0.03) and Group 3 (p<0.001) following transfusion, but the change was not 
significant in the Group 2 infants (p=0.16). The mean pre-transfusion cerebral tissue 
oxygenation index (cTOI) levels were significantly lower in group 3 compared to group 1 
(p=0.02). The cerebral tissue haemoglobin level cTHI (p<0.001) and cTOI (p<0.05) 
increased significantly post-transfusion in all the three groups. The percentage increase in 
post-transfusion cTOI from baseline was 5%, 11% and 12% in group 1, group 2 and group 3 
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infants respectively. On comparing infants with PDA (n=14) to gestational and chronological 
age matched controls (n=14), there was no significant difference in these measurements. 
 
Baseline cTOI decrease and ACA TAMV increase with increasing chronological age. Blood 
transfusion increased cTOI and cTHI, and decreased ACA TAMV in all age group of infants 
but the proportion of response is different. PDA had no impact on the baseline cerebral 
oximetry and blood flow as well as changes following transfusion. Future transfusion trials 
should take into account the impact of postnatal age on cerebral oximetry and blood flow. 
 
 
 
Keywords: cerebral oximetry, blood transfusion, cerebral blood flow 
 
Abbreviations:  
ACA – anterior cerebral artery, APH – antepartum haemorrhage, cTOI – cerebral tissue 
oxygenation index, cTHI – cerebral tissue haemoglobin index, CrSO2 – cerebral regional 
oxygen saturation, FOEC – fractional oxygen extraction capacity, GA – gestational age, Hb – 
haemoglobin, IUGR – intra-uterine growth restriction, PDA – patent ductus arteriosus, PET – 
pre-eclampsia, PI – pulsatility index, PSV – peak systolic velocity, RI – resistance index, 
SVC – superior vena cava, TAMV – time averaged mean velocity, VTI – velocity time 
integral  
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Introduction 
In neonatal intensive care units preterm infants undergo frequent blood tests to monitor their 
haemodynamic and oxygenation status. As a result of regular phlebotomy losses and their 
inability to maintain haemoglobin levels, one of the common practices in neonatal units is to 
transfuse blood with an intention to maintain optimal tissue oxygenation in order to promote 
growth and weight gain1. While transfusion is beneficial in the setting of acute perinatal blood 
losses and severe anaemia, its advantage in moderate grades of anaemia in stable preterm 
infants remain uncertain1. Blood transfusion has been reported to be an independent risk 
factor of mortality2,3 and in the first weeks of life has been linked to progression of intra-
ventricular haemorrhage4 in preterm infants. The threshold for transfusion in preterm infants 
remain controversial and has led to several randomised controlled trials using liberal and 
restrictive thresholds for blood transfusion with conflicting reports on neurological outcomes 
5-7. Whether these thresholds were not optimal or whether haemoglobin concentration in the 
blood does not correlate with tissue oxygenation measurements8-10 remains to be answered. 
Other studies have shown conflicting reports regarding improvement of short term effects of 
apnoea, tachycardia and bradycardia following transfusion 1,11,12. In current practice various 
clinical, laboratory and bedside biomarkers are regularly used to identify the need for 
transfusion in preterm infants13. Reducing blood tests, advanced point of care blood 
analysers requiring smaller volume of blood14 and implementing restrictive transfusion 
guidelines have reduced the frequency of transfusions in most neonatal units15. Two 
randomised clinical trials are currently undergoing to detect whether receiving restrictive or 
liberal blood transfusions improve long term neurodevelopmental outcomes in preterm 
infants16,17.  
 
One of the principal objectives of blood transfusion in preterm infants is to prevent impaired 
tissue oxygenation in the brain and other vital organs. But the threshold at which the 
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demands of the tissue exceed the oxygen content of the blood remains unknown. Apart from 
autoregulatory mechanisms of certain organs such as brain 18, increased blood flow and 
increased tissue oxygen extraction are two other main processes to maintain adequate 
oxygenation to support metabolism in the tissues (Reference). Peripheral arterial saturation, 
tachycardia and serum lactate 19,20 gives a realistic estimate of the haemodynamic status of 
the systemic circulation but fails to identify specific tissue needs. Blood flow to various 
organs could be measured at the bedside using Doppler ultrasound scan of contributing 
arteries, and systemic haemodynamic status could be measured by left or right ventricular 
output 21 as well as venous return from superior vena cava22. These are excellent non-
invasive bedside measurements of assessing blood flow to vital organs but are not 
continuous and are a snapshot of the state of organ perfusion in specific timeframe. Other 
measures such as continuous measurement of cardiac output in paediatrics and neonates 
using transthoracic electrical bioimpedence is still in its early stage of validation and 
development 23. It has been reported earlier that anaemic stable preterm infants could be at 
a clinically unrecognised high cardiac output state, which could lead to reduced oxygen 
delivery to brain 24. This might in turn lead to cerebral haemorrhage and brain injury 25. Near 
infra-red spectroscopy (NIRS) is a validated method of continuous measurement of cerebral 
tissue oxygenation 26 and cerebral blood volume in preterm infants27,28. NIRS have been 
used in various observational studies to measure cerebral tissue oxygenation in the past 20-
30 years 29. Recently, to highlight its efficacy in clinical practice as a tool to assess cerebral 
oximetry in preterm infants, NIRS have been used in various randomised clinical trials. 
Cerebral NIRS oximetry is currently being studied to aid in newborn resuscitation in delivery 
room 30, to monitor cerebral autoregulation 31 and daily monitoring in neonatal units 32, and 
its role in management in neonatal hypotension 33,34. 
 
Cerebral NIRS oximetry has been used in the past to assess the effect of blood transfusion 
in older stable preterm infants 9,10,35. But the effect on cerebral perfusion and oximetry in pre-
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transfusion anaemic state and response to blood transfusion in different gestational and 
chronological ages remains unknown. The aim of this study was to measure the effect of 
blood transfusion on cerebral blood flow and oxygenation in preterm infants according to 
chronological age using Doppler ultrasound scan and NIRS.  
 
Materials and Methods 
The study was conducted at Homerton University Hospital, a tertiary level neonatal unit in 
London, UK. Preterm infants receiving blood transfusion for clinical indication were eligible 
for the study. The infants were recruited into three groups depending on their postnatal age: 
Group 1: day 1 to day 7 of life, Group 2: day 8 to 28 days of life and Group 3: more than 28 
days of life. Major congenital anomalies and infants considered unstable for Doppler 
ultrasound or NIRS measurements by the attending clinical team were excluded. A 
pragmatic sample size of 20 infants per group was considered. Blood transfusion in our 
neonatal unit followed current British Committee for Standards in Haematology (BCSH) 
guidance 36 with 15 ml/kg of packed red blood cells were transfused over a period of 3 hours.  
 
Cerebral blood flow measurements 
The Doppler measurements were performed using an ultrasound scanner with a 7 MHz 
probe (Logic P6, GE Healthcare, US). The anterior cerebral artery (ACA) peak systolic and 
time averaged mean velocities (TAMV) as well as pulsatility and resistance indices were 
measured 30-60 minutes pre and post blood transfusion using a range-gated pulsed wave 
Doppler ultrasound scan placing the probe over the anterior fontanel in parasagittal view. 
Superior vena cava (SVC) flow was measured using the classical method by placing the 
probe in the infra-diaphragmatic view to measure the velocity time integral (VTI) and then 
again over the true long axis to measure the diameter of the SVC pre and post blood 
7 | P a g e  
 
transfusion. The Doppler measurements were performed by single operator (JB) to minimise 
intra-operator variability and utmost care was taken to minimise the angle of insonation to 
the direction of flow. When this was more than 30° angle correction was performed. Cardiac 
morphology and presence of patent ductus arteriosus (PDA) was also recorded. 
 
Cerebral oxygenation measurements 
Cerebral oxygenation was measured using a NIRS device (NIRO 300, Hamamatsu 
Photonics Limited, Japan) with a sample acquisition rate of 6 Hz/sec. The NIRS probe was 
attached to the infant’s forehead and held in place by the hat used for conventional or non-
invasive ventilation; utmost care was taken to minimise any movement and ambient light 
interference. To reduce NIRS motion artefacts the infants were minimally handled during the 
study period. The cerebral tissue Hb Index (cTHI) in arbitrary units and tissue oxygenation 
index (cTOI) in percentage were continuously measured from 15-20 min before, during and 
15-20 min post blood transfusion, and downloaded into the research laptop.  
 
Vital parameters measurements  
The vital parameters such as heart rate (HR), respiratory rate (RR), blood pressure (BP) and 
saturation were measured using Phillips Intellivue monitor (MP50/MP70) during NIRS 
measurements, and downloaded continuously using ixTrend 2.0 software (ixellence GmBH, 
Halle, Germany) into the research laptop.   
 
Laboratory parameters measured  
The pre and post blood transfusion laboratory parameters such as hemoglobin (Hb), 
hematocrit (Hct) and blood gas parameters such as pH, pCO2 and serum lactate were also 
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measured. Hb and Hct were measured using flow cytometry (Beckman Coulter Inc. US) in 
the hospital lab and the blood gas parameters were measured by blood gas machine (GEM 
Premier 4000, Instrumentation Laboratory, UK) in the neonatal unit.  
 
Additional data collected 
Antenatal factors: antepartum haemorrhage (APH), maternal pre-eclampsia (PET) and intra-
uterine growth restriction (IUGR), chorioamnionitis; and infant characteristics: gestational 
age, birth weight, Hb at birth were collected. Clinical condition on the day of transfusion: 
ventilation status and inotropic support were recorded. 
 
The study was approved by the National Research Ethics Committee (REC no.12/LO/0527) 
and was adopted as an NIHR portfolio study (NIHR Study ID 13594). Informed written 
parental consent was obtained.  
 
Data analysis 
A mean for 15 minute epochs of NIRS and vital parameter measurements were determined 
for each infant using mathematical software Mat Lab R2013b (Math works, USA) during the 
following time periods: T1 - 15 to 20 minutes before the start of the blood transfusion, T2 - 1 
hour into blood transfusion, T3 - 2 hour into blood transfusion and T4 - 15 to 20 minutes post 
blood transfusion. The serial measurements of all studied variables were compared using 
repeated measures analysis ANOVA with Bonferroni method. The pre and post-transfusion 
values of all measurements and the NIRS measurements at all above time points were 
compared using paired two-tailed t-test, the various clinical groups as well as the 
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chronological age groups were compared using ANOVA and t-tests. A p value of <0.05 was 
considered significant. The data was analysed using SPSS 22.0 software (IBM Corp., USA). 
 
Results 
 
Infant characteristics 
 
Fifty nine infants were studied; infant and maternal characteristics are presented in Table 1. 
The mean birth weight and gestational age of infants studied in the three groups were 
similar. The infant characteristics on the day of blood transfusion are presented in Table 2. 
32 infants had PDA on echocardiography, of these only six were >14 days of postnatal age; 
otherwise normal cardiac morphology. Majority of infants in group 1, and eight each in the 
other two groups were receiving antibiotics for presumed sepsis; blood culture results were 
noted to be subsequently negative for all. Three infants in group 1, two in group 2 and one in 
group 3 were on single inotropic support (Dopamine) for hypotension, the dose remained 
unchanged for the duration of the measurements. Three infants in group 1, two in group 2 
and three in group 3 had significant IVH (≥grade 4) noted before transfusion. There was no 
progression of these findings following transfusion in any of the three groups. 
 
 
Vital signs and laboratory parameters  
 
The mean values of pre and post blood transfusion vital parameters and laboratory 
parameters are presented in Table 3. The mean pre-transfusion RR, HR and saturation 
were similar between infants of three groups except the mean pre-transfusion HR was 
higher in group 1 compared to group 3 (p=0.02, 95% CI 1.5 to 16.6). There was no 
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significant change in HR, RR and saturation following blood transfusion in all three groups of 
infants. Systolic BP increased significantly following blood transfusion in group 1 infants, 
where as diastolic and mean BP increased significantly in all the three groups. The serum 
lactate levels decreased significantly in group 1 and 2 infants following blood transfusion. 
However, the mean pre and post blood transfusion pH and pCO2 levels in the blood gas 
remained unaltered in infants of all three groups. The mean pre-transfusion haemoglobin 
was higher in group 1 compared to group 2 (p=0.03, 95% CI 0.07 to 1.56) and group 3 
(p<0.001, 95% CI 1.25 to 2.88). There was significant increase in post-transfusion Hb in all 
three groups of infants (Table 3).  
  
 
Doppler measurements 
 
The mean pre-transfusion anterior cerebral artery (ACA) peak systolic velocity (PSV) was 
higher in group 2 infants compared to group 1 (p=0.06) and group 3 infants compared to 
group 2 (p=0.11) but this was not significant. The mean pre-transfusion ACA TAMV was 
significantly higher in group 3 (0.27±0.07 m/sec) compared to group 1 (0.17±0.05 m/sec; 
p<0.0001, CI 0.06 to 0.14), and group 3 compared to group 2 (0.19±0.06, p<0.001, CI 0.03 
to 0.12). The mean pre-transfusion ACA peak systolic velocity (PSV) and time averaged 
mean velocity (TAMV) decreased significantly post-transfusion in all the three groups (Table 
4 and Figure 1). The mean pre-transfusion ACA Resistance Index (RI) and Pulsatility Index 
(PI) were similar in infants of all three groups, and there was no significant change in ACA RI 
and PI following transfusion in all three groups. The mean pre-transfusion Superior Vena 
cava (SVC) flow was higher in group 1 infants compared to other two groups and was higher 
in group 3 compared to group 2 infants but this was not significant. The mean SVC flow 
decreased significantly following transfusion in Group 1 and 3 infants but there was no 
significant change in Group 2 infants (Table 4 and Figure 1).  
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Doppler measurements in infants with PDA 
 
Doppler measurement of infants with PDA (n=11, mean gestational age=25 wks & Mean 
chronological age=16 days) compared to gestational age (mean=26 wks) and chronological 
age (mean=17 days) matched infants with closed PDA (n=11). The pre-transfusion mean 
ACA TAMV was similar in the infants with PDA (0.19±0.05 m/s) compared to those with 
closed PDA (0.21±0.07 m/s, p = 0.45, CI -0.07 to 0.03). The mean pre-transfusion SVC flow 
was similar between the PDA (102.98±42.5 ml/kg/min) and closed-PDA group (87.66±30.3 
ml/kg/min, p=0.352 95% CI -16.09 to 46.7). The ACA TAMV decreased significantly 
following blood transfusion in both PDA group (p=0.04, CI 0.01 to 0.05) and the closed-PDA 
group (p=0.01, CI 0.01 to 0.06) of infants. The SVC flow also remained similar following 
transfusion in both PDA (p=0.99, CI -13.5 to 13.3) as well as the closed-PDA (p=0.83, CI -
11.5 to 9.4) group.  
 
NIRS measurements 
 
Cerebral tissue haemoglobin index (cTHI) 
 
The percentage changes in the mean pre-transfusion baseline cerebral tissue haemoglobin 
index (cTHI) values are shown in Figure 2. There was a consistent increasing trend in cTHI 
levels following blood transfusion in infants of all three groups except an initial drop in the 
first hour of transfusion in Group 1. Whereas the maximal increase in cTHI happened earlier 
in Group 3, the percentage increase maximised post-transfusion in all the three groups 
(p<0.001; Table 5). The cTHI increased at a higher rate following transfusion in older 
preterm infants in Group 3 compared to the infants in their first week of life (Group 1; Figure 
2).  
 
Cerebral tissue oxygenation Index (cTOI) 
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The mean pre-transfusion cTOI levels were significantly lower in group 3 infants compared 
to group 1 (p=0.02, 95% CI 2.09 to 25.44). The mean pre-transfusion cTOI increased 
significantly following transfusion in all the three groups. There was an increasing trend in 
mean cTOI over time but it did not reach statistical significance until the end of transfusion 
(Table 5; Figure 2). The percentage increase in post-transfusion cTOI from baseline was 
5%, 11% and 12% in group 1, group 2 and group 3 infants respectively.  
 
NIRS measurements in infants with PDA and those with closed PDA 
 
The baseline mean pre-transfusion cTOI was higher in the PDA group (69±13.4 %) 
compared to the closed-PDA group (63.16±13.6%) but this was not significant (p=0.24, CI -
5.01 to 18.66). Similar pattern of increase was noticed in cTOI in both the groups during 
blood transfusion (Figure 3). The cTOI increased significantly in all the time points at 1 hour, 
2 hours and post-transfusion when compared to baseline pre-transfusion values in both the 
groups with and without PDA (Figure 3). The cTHI significantly increased consistently at all 
the time points and was similar in infants with or without PDA (Figure 3).   
 
 
Discussion 
We have shown that blood transfusion in preterm infants increased cerebral tissue 
oxygenation index (cTOI) as well as cerebral tissue haemoglobin index (cTHI) during the first 
week (group 1), 8th to 28th day (group 2) and >28 days of life. Cerebral regional tissue 
oxygenation (CrSO2) also referred to as cTOI is a biomarker of tissue oxygenation and they 
represent the percentage of oxygenated Hb compared to the total Hb in the tissue traversed 
by the near infra-red light 37. cTHI is another cerebral tissue oxygenation biomarker, and 
indicates the total concentration of Hb in the tissues and in essence the changes in red cell 
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volume in the tissues. For the first time we have demonstrated that the response of cerebral 
tissue oxygenation following transfusion is dependent on the postnatal age of the preterm 
infant. Similar to the present study other researchers have shown increase in CrSO2 and 
decrease in cerebral fractional oxygen extraction (FOEC) following transfusion in stable 
preterm infants with a gestational age range between 25 and 34 weeks 8-10,38. In these 
studies preterm infants of 5 to 93 days of age with a wide range of pre-transfusion Hb were 
clubbed together as a single group. In the present study infants were divided into three 
groups based on postnatal age to minimise the effect of postnatal maturity on 
haemodynamic changes measured. We have also demonstrated that as postnatal age of 
infant increases, the baseline pre-transfusion cTOI decreased. Similar to the present study 
findings, McNeill et al reported a decrease in CrSO2 as infant’s chronological age increased 
by studying 14 preterm infants between 29 to 34 weeks of gestation39. The pre-transfusion 
cTOI  during the first week of life in the present study is comparable to the reported 
normative values of 57 to 75% 40. The lower pre-transfusion cTOI in older preterm infants in 
the current study could be due to lower pre-transfusion Hb levels or physiological 
maturational changes. The percentage increase in cTOI as well as cTHI was also different in 
the chronological age groups in the current study, demonstrating variable effect of blood 
transfusion in different postnatal ages. The cTHI levels increased in all chronological age 
groups indicating an increase in cerebral blood volume following blood transfusion. 
Calculating from changes in cerebral total Hb concentration using NIRS in 14 preterm infants 
(mean gestational age 29.6±2.6 and mean birth weight 1430±332 grams), Dani et al have 
demonstrated an increase in cerebral blood volume following transfusion 35.  
 
To better appreciate the effects of blood transfusion on cerebral blood flow we also 
measured blood flow velocity in anterior cerebral artery (ACA) and blood flow volume in 
superior vena cava (SVC). Previously it has been reported that blood flow velocity in the 
ACA 41 and pericallosal artery 38 decreases following blood transfusion, possibly due to 
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increased resistance in the cerebral blood flow due to increased viscosity of blood 42. 
Significant increase in the diastolic blood pressure in the current study indirectly indicates 
increase in peripheral vascular resistance. In accordance with the findings of the previous 
studies we have also demonstrated decrease in the mean ACA TAMV in all the three 
chronological age groups. Researchers studied by merging infants of various gestational and 
chronological age together as one group in previous studies35,41, where as we studied by 
dividing infants into three groups according to postnatal age. In the current study, the 
baseline pre-transfusion blood flow velocity as well as their response to blood transfusion 
was different in three infant groups studied. The mean ACA TAMV was lower during the first 
week of life (group 1 infants) and significantly higher in infants who were more than 28 days 
old (group 3 infants). This may be due to maturational changes but also could be attributed 
to group 3 infants being transfused at a lower Hb compared to the group 1 infants. We have 
also demonstrated for the first time that the SVC blood flow volume decreases following 
blood transfusion during the first week of life and in the infants who were more than 4 weeks 
of age. A previous study has shown that anaemic preterm infants develop a high cardiac 
output state and this decrease significantly on blood transfusion 24. There was no change in 
the SVC flow in the Group 2 infants perhaps indicating a more stable cardiovascular state or 
blood being transfused at a higher baseline Hb level before any haemodynamic 
decompensation. We have also demonstrated for the first time that the pre-transfusion 
baseline SVC flow was higher in the early preterm infants compared to the older preterm 
group. This could be due to poor cerebral autoregulation in the earlier preterm group thereby 
demonstrating a higher blood flow volume to the brain.  
 
For the first time we have demonstrated the interaction of PDA on the cerebral blood flow 
and oxygenation response to blood transfusion in gestational and chronological age 
matched preterm infants. The baseline pre-transfusion mean ACA TAMV and SVC flow were 
similar between the groups with open and closed PDA thereby demonstrating similar upper 
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body blood flow in either group. The mean baseline pre-transfusion cTOI level in the preterm 
infants with open PDA was also similar to those with closed PDA. This exhibits 
compensatory mechanism by which the upper body blood flow is maintained and so is the 
cerebral tissue oxygenation in the presence of PDA. The increase in cTHI and cTOI levels 
during transfusion was similar in both groups which indicate that PDA has no effect on the 
cerebral blood flow and oximetry response to blood transfusion.  
 
There was no change in heart rate (HR) following blood transfusion in all three infant groups 
studied in the present study but other researchers have reported a significant decrease in 
heart rate41,43. Previous studies in older clinically stable preterm infants have reported no 
significant difference in mean blood pressure following blood transfusion 38,41; we have 
demonstrated significant increase in the mean blood pressure following blood transfusion in 
all the three groups. The mean blood pressure was higher in the older preterm group 
compared to the earlier preterm infants, it is well recognised that mean blood pressure in 
preterm infants increases with postnatal age 44. We did not notice any change in SaO2 and 
respiratory rate following blood transfusion any of the three groups of infants. In older 
preterm infants, Fredrickson et al also did not notice any difference in the SaO2, FiO2 and 
oxygen consumption between two groups receiving liberal and restrictive transfusion 45. 
There was a significant drop in serum lactate levels following blood transfusion in infants 
less than 28 days of age (Group 1 and 2) despite normal pre-transfusion levels but there 
was no change in older infants (group 3). Hence, use of serum lactate as a trigger for blood 
transfusion in preterm infants 13,20 is debatable.  
 
Leukocyte depleted cytomegalovirus negative, Sickle cell negative, plasma reduced packed 
red blood cells (hematocrit 50-70%), were transfused over a period of 3 hours through an 
intravenous cannula which is a standard practice in most neonatal units in the UK. The 
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ventilatory pressures, oxygen requirement, feeding regime, the pre-transfusion pH and pCO2 
remained unchanged during the study period. The mean pre-transfusion Hb and Hct were 
comparable to the reported studies 6,10,43.        
 
Decision for transfusion was made by the attending clinician based on measured Hb and 
clinical condition of the infant. Hence, selection bias cannot be excluded. The pragmatic 
estimated sample size was 20 infants per group based on chronological age. We recruited 
appropriate number of infants to group 1 and 2 but recruited only 18 infants to group 3 (≥28 
days of life). This is unlikely to influence the study findings. Fewer babies were ventilated in 
group 3 compared to group 1 and 2. However, the pre and post transfusion blood gas pH 
and pCO2PC2 were similar in all three groups of infants studied, and hence ventilator status 
is unlikely to have impact on the study findings. Since Doppler ultrasound scan 
measurements are operator dependent, the measurements were performed by a single 
operator (JB) to minimise intra-operator variability. The cerebral oxygenation measurements 
of seven infants were excluded from the analysis due to motion artefacts, which is 
comparable to other reported NIRS studies28,46. One of the limitations of the study is that we 
measured the cerebral tissue oxygenation upto 20 minutes following transfusion. Other 
researchers have measured cerebral tissue oxygenation at one 35, four and 24 hours 10 post-
transfusion, and reported persistence of increased tissue oxygenation state following 
transfusion in more stable preterm infants. Six infants were receiving Dopamine 
(5mcg/kg/min) and this is unlikely to influence the study findings as the dosage of Dopamine 
infusion remained unchanged for the duration of the measurements.  
 
Conclusion 
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We have shown that the baseline cTOI decreases with increasing chronological age of 
preterm infants. Blood transfusion increases cTOI and cTHI in preterm infants of all 
chronological age groups but this is more pronounced after 28 days of life. The baseline 
ACA TAMV increases as infant’s chronological age increase. The SVC flow decrease after 
1st week of life but not consistently. The cerebral perfusion decrease following blood 
transfusion during the first week and after 28 days of life in preterm infants. Presence of PDA 
has no impact on the cerebral blood flow and oximetry response to blood transfusion; similar 
pre-transfusion baseline values indicate compensatory mechanisms by which the preterm 
body adapts to PDA to maintain cerebral blood flow and oxygenation. These findings 
indicate that cerebral blood flow and oximetry response to blood transfusion in preterm 
infants is dependent on the chronological age of the infant, and future randomised trials of 
blood transfusion should be planned taking into account the effect of postnatal age on 
cerebral blood flow and oximetry.  
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Table 1. Infant and maternal characteristics 
Characteristics 
 
Group 1 (1 – 7 ds) 
n = 20 
Group 2 (8 – 28 ds) 
n = 21 
Group 3 (>28 ds) 
n = 18 
Gestational age  
(completed weeks)* 
26 (23 – 27) 25 (23 – 30) 26 (24 – 34) 
Birth weight (grams)* 763 (600 – 1180) 740 (600 – 1240) 793 (520 – 1746) 
Chronological age (days)* 5 (1 – 7) 14 (8 – 27) 45 (29 – 93) 
Haemoglobin at birth 
(g/dl)* 
14.5 (9.8 – 20.7) 14.7 (10.0 – 17.4) 15.3 (10 – 18.9) 
Maternal PET† 3 (15) 5 (24) 4 (22) 
IUGR† 3 (15) 5 (24) 4 (22) 
Chorioamnionitis† 9 (45) 8 (38) 8 (44) 
Antepartum 
haemorrhage† 
6 (30) 8 (38) 4 (22) 
Antenatal steroids† 17 (85) 20 (95) 16 (89) 
 
† Number (percentage), * Median (Range) 
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Table 2. Infant characteristics at blood transfusion 
 
Characteristics 
 
Group 1 (1 – 7 ds) 
n = 20 
Group 2 (8 – 28 ds) 
n = 21 
Group 3 (>28 ds) 
n = 18 
Weight at transfusion 
(grams)* 
774 (700 – 1180) 805 (680 – 1250) 1125 (887 – 2045) 
Pre-transfusion Hb (g/dl)* 11.0 (8.5 – 13.1) 10.3 (7.7 – 12.2) 9.2 (7 – 10.9) 
Total fluids (ml/kg/d)* 150 (90 – 180) 150 (100 – 180) 165 (100 – 180) 
Invasive/Non-invasive 
ventilation/nasal cannula 
oxygen or breathing in 
air† 
13 (65)/7(35) 13 (62)/7 (33)/1 (5) 6 (33)/9 (50)/3 (17) 
Presence of PDA† 19 (95) 12 (57) 1 (6) 
Presumed sepsis on 
antibiotics† 
19 (95) 8 (38) 8 (44) 
 
† Number (percentage), * Median (Range) 
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Table 3. Blood transfusion (BT), vital and laboratory parameters  
Vital and laboratory parameters 
Mean (SD) 
Group 1 (1 – 7 days) 
n = 20 
Group 2 (8 – 28 days) 
n = 21 
Group 3 (>28 days) 
n = 18 
 Pre-BT Post-BT p value Pre-BT Post-BT p value Pre-BT Post-BT p value 
Heart rate (bpm) 159.1 (8.8) 157.1 (15.1) 0.67 153 (13.4) 153 (14.9) 0.99 150.0 (11.7) 149.4 (13.0) 0.90 
Respiratory rate (bpm) 53.2 (12.3) 50 (11.7) 0.13 48.5 (10.2) 48.4 (8.3) 0.91 52.8 (13.9) 52.1 (11.4) 0.73 
Arterial saturation (SaO2)% 93.2 (2.9) 93.2 (2.5) 0.96 91.9 (3.5) 92.3 (4.0) 0.67 93.0 (3.8) 93.2 (4.1) 0.88 
Systolic BP (mm of Hg) 46.7 (6.6) 51.6 (4.9) <0.01 54.9 (9.6) 57.7 (11.7) 0.07 62.2 (14.0) 63.7 (12.1) 0.45 
Diastolic BP (mm of Hg) 24.3 (3.1) 30.7 (4.7) <0.01 31.4 (5.4) 35.8 (8.3) <0.01 31.3 (6.0) 36.2 (6.6) 0.01 
Mean BP (mm of Hg) 32.7 (3.7) 37.9 (3.7) <0.01 39.9 (6.3) 43.4 (8.1) 0.02 43.2 (7.9) 46.2 (6.6) 0.02 
Haemoglobin (g/dl) 11.2 (1.3) 13.0 (1.6) <0.01 10.3 (1.0) 13.5 (1.1) <0.01 9.1 (1.2) 12.2 (1.2) <0.01 
Haematocrit 0.32 (0.04) 0.40 (0.05) <0.01 0.29 (0.03) 0.39 (0.04) <0.001 0.25 (0.04) 0.36 (0.03) <0.01 
pH 7.3 (0.07) 7.3 (0.05) 0.50 7.3 (0.05) 7.3 (0.06) 0.57 7.3 (0.05) 7.3 (0.05) 0.30 
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pCO2 5.8 (1.2) 5.9 (0.9) 0.47 6.6 (1.0) 6.7 (1.3) 0.72 6.9 (1.4) 6.6 (1.5) 0.11 
Lactate (mmol/l) 2.5 (1.3) 1.8 (0.5) 0.02 1.5 (0.7) 0.9 (0.5) 0.03 1.3 (0.6) 1.3 (0.4) 0.82 
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Table 4. Blood transfusion (BT) and cerebral Doppler blood flow parameters 
 
Blood flow parameters 
Mean (SD) 
Group 1 (1 – 7 days) 
n = 20 
Group 2 (8 – 28 days) 
n = 21 
Group 3 (>28 days) 
n = 18 
 Pre-BT Post-BT p value Pre-BT Post-BT p value Pre-BT Post-BT p value 
ACA peak systolic velocity (m/sec) 0.32 (0.09) 0.27 (0.09) 0.04* 0.38 (0.11) 0.33 (0.09) 0.02* 0.54 (0.14) 0.44 (0.09) 0.04* 
ACA time averaged mean velocity (m/sec) 0.17 (0.05) 0.14 (0.04) 0.01* 0.19 (0.04) 0.16 (0.05) <0.01* 0.27 (0.07) 0.23 (0.05) <0.01* 
ACA RI 0.82 (0.07) 0.83 (0.05) 0.65 0.86 (0.05) 0.85 (0.07) 0.57 0.84 (0.07) 0.83 (0.07) 0.66 
ACA PI 1.53 (0.25) 1.56 (0.20) 0.67 1.73 (0.26) 1.68 (0.30) 0.53 1.70 (0.32) 1.58 (0.26) 0.57 
SVC flow (ml/kg/min) 110.1 (55.9) 96.6 (40.7) 0.03* 91.0 (35.1) 95.5 (39.5) 0.16 98.9 (22.6) 77.9 (23.6) <0.01* 
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Table 5. Blood transfusion (BT) and cerebral NIRS parameters 
 
Cerebral oximetry parameters 
Mean (SD) 
Group 1 (1 – 7 days) 
n = 17† 
Group 2 (8 – 28 days) 
n = 20†† 
Group 3 (>28 days) 
n = 15††† 
 Pre-BT Post-BT p value Pre-BT Post-BT p value Pre-BT Post-BT p value 
Cerebral tissue haemoglobin 
index (cTHI) (percentage 
increase from baseline) % 
Zeroed 
baseline 
50.58 <0.001 Zeroed 
baseline 
63.18 <0.001 Zeroed 
baseline 
68.22 <0.001 
Cerebral tissue oxygenation 
index (cTOI) % 
71.0 (15.8) 74.6 (12.6) <0.05 63.0 (12.3) 73.7 (11.8) <0.01 57.2 (13.2) 64.1 (12.6) <0.01 
 
† 3 infants, †† 1 infant and ††† 3 infants excluded from this analysis due to motion artefacts 
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Figure 1. Blood transfusion (BT) and changes in ACA TAMV and SVC flow 
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Figure 2. Blood transfusion (BT) and changes in cerebral NIRS parameters 
T1 - 15 to 20 minutes before the start of the blood transfusion, T2 - 1 hour into blood 
transfusion, T3 - 2 hour into blood transfusion and T4 - 15 to 20 minutes post blood 
transfusion 
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Figure 3. Changes in cTOI and cTHI (± SEM) in the infants in the PDA and closed-PDA 
groups following blood transfusion 
T1 - 15 to 20 minutes before the start of the blood transfusion, T2 - 1 hour into blood 
transfusion, T3 - 2 hour into blood transfusion and T4 - 15 to 20 minutes post blood 
transfusion 
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